Drupal.behaviors.print = function(context) {window.print();window.close();}>

Evotec Completes DeveloGen Acquisition

September 02, 2010

Evotec Completes DeveloGen Acquisition

The acquisition adds drug discovery alliances to Evotec's portfolio of core assets, including one with Boehringer Ingelheim worth up to €237 million in potential milestone payments.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories